Weiss Günter, Schaible Ulrich E
Department of Internal Medicine VI, Infectious Disease, Immunology, Rheumatology, Pneumology, Medical University of Innsbruck, Innsbruck, Austria.
Immunol Rev. 2015 Mar;264(1):182-203. doi: 10.1111/imr.12266.
Macrophages and neutrophils play a decisive role in host responses to intracellular bacteria including the agent of tuberculosis (TB), Mycobacterium tuberculosis as they represent the forefront of innate immune defense against bacterial invaders. At the same time, these phagocytes are also primary targets of intracellular bacteria to be abused as host cells. Their efficacy to contain and eliminate intracellular M. tuberculosis decides whether a patient initially becomes infected or not. However, when the infection becomes chronic or even latent (as in the case of TB) despite development of specific immune activation, phagocytes have also important effector functions. Macrophages have evolved a myriad of defense strategies to combat infection with intracellular bacteria such as M. tuberculosis. These include induction of toxic anti-microbial effectors such as nitric oxide and reactive oxygen intermediates, the stimulation of microbe intoxication mechanisms via acidification or metal accumulation in the phagolysosome, the restriction of the microbe's access to essential nutrients such as iron, fatty acids, or amino acids, the production of anti-microbial peptides and cytokines, along with induction of autophagy and efferocytosis to eliminate the pathogen. On the other hand, M. tuberculosis, as a prime example of a well-adapted facultative intracellular bacterium, has learned during evolution to counter-balance the host's immune defense strategies to secure survival or multiplication within this otherwise hostile environment. This review provides an overview of innate immune defense of macrophages directed against intracellular bacteria with a focus on M. tuberculosis. Gaining more insights and knowledge into this complex network of host-pathogen interaction will identify novel target sites of intervention to successfully clear infection at a time of rapidly emerging multi-resistance of M. tuberculosis against conventional antibiotics.
巨噬细胞和中性粒细胞在宿主对包括结核分枝杆菌(TB)病原体在内的细胞内细菌的反应中起决定性作用,因为它们代表了针对细菌入侵者的固有免疫防御的前沿。同时,这些吞噬细胞也是细胞内细菌滥用宿主细胞的主要靶标。它们遏制和消除细胞内结核分枝杆菌的效力决定了患者最初是否会被感染。然而,尽管发生了特异性免疫激活,但当感染变为慢性甚至潜伏性(如结核病的情况)时,吞噬细胞也具有重要的效应功能。巨噬细胞已经进化出无数的防御策略来对抗细胞内细菌感染,如结核分枝杆菌。这些策略包括诱导产生有毒的抗菌效应分子,如一氧化氮和活性氧中间体;通过吞噬溶酶体中的酸化或金属积累刺激微生物中毒机制;限制微生物获取铁、脂肪酸或氨基酸等必需营养物质;产生抗菌肽和细胞因子;以及诱导自噬和胞葬作用以消除病原体。另一方面,作为适应性良好的兼性细胞内细菌的典型例子,结核分枝杆菌在进化过程中学会了平衡宿主的免疫防御策略,以确保在这个原本充满敌意的环境中生存或繁殖。本综述概述了巨噬细胞针对细胞内细菌的固有免疫防御,重点是结核分枝杆菌。在结核分枝杆菌对传统抗生素迅速出现多重耐药性的时代,深入了解这一复杂的宿主-病原体相互作用网络将有助于确定新的干预靶点,以成功清除感染。